On November 22, 2024, BioVie filed a Form S-8 with the SEC to register securities under its amended 2019 Omnibus Equity Incentive Plan. This registration allows the company to offer equity incentives to its employees, directors, and consultants. The plan was amended and restated through August 28, 2024.BioVie, a Nevada corporation, is classified as a non-accelerated filer and a smaller reporting company. The filing incorporates by reference several of BioVie's previous reports, including the annual report for the fiscal year ended June 30, 2024, and the quarterly report for the period ended September 30, 2024.The registration statement includes provisions for indemnification of directors and officers, as permitted by Nevada law, and outlines the company's ability to purchase insurance for these individuals.

On November 22, 2024, BioVie filed a Form S-8 with the SEC to register securities under its amended 2019 Omnibus Equity Incentive Plan. This registration allows the company to offer equity incentives to its employees, directors, and consultants. The plan was amended and restated through August 28, 2024.BioVie, a Nevada corporation, is classified as a non-accelerated filer and a smaller reporting company. The filing incorporates by reference several of BioVie's previous reports, including the annual report for the fiscal year ended June 30, 2024, and the quarterly report for the period ended September 30, 2024.The registration statement includes provisions for indemnification of directors and officers, as permitted by Nevada law, and outlines the company's ability to purchase insurance for these individuals.